Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
SUSPENDED
NCT04896827

DNIC Using Deep Learning and Artificial Intelligence

Sponsor: Université de Sherbrooke

View on ClinicalTrials.gov

Summary

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.

Official title: Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence

Key Details

Gender

All

Age Range

18 Years - 79 Years

Study Type

OBSERVATIONAL

Enrollment

244

Start Date

2022-04-05

Completion Date

2028-12

Last Updated

2026-05-28

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Conditioned pain modulation test

Conditioned pain modulation (CPM) protocol consist of evaluating pain during a heat test, before and after one conditioning stimulus (cold water bath); 3 cameras will be capturing participants' facial expressions during the tests.

Locations (1)

Université de Sherbrooke

Sherbrooke, Quebec, Canada